View More View Less
  • 1 Ordu University, Turkey
  • | 2 Recep Tayyip Erdoğan University, Turkey
  • | 3 Ordu University, Turkey
  • | 4 Recep Tayyip Erdoğan University, Turkey
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Resistance to β-lactams in Enterobacteriaceae has been increasing worldwide. This study aimed to determine the frequency of β-lactamase genes and antibiotic resistance rates of 140 extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates obtained from urinary tract infection in Ordu Province, Turkey. Isolates were identified by classic methods and by automated system. ESBL production was confirmed by double disk synergy test and antimicrobial susceptibility was investigated by disk diffusion method. All isolates were screened for β-lactamase coding genes from three groups (A, B, and D) by polymerase chain reaction. The highest rate of susceptible isolates was observed for imipenem (IPM, 99.3%) and ertapenem (ETP, 97.9%), and the highest rate of resistant isolates was observed for cefuroxime (97.9%), ceftriaxone (97.2%), and cefazolin (90.7%). In our study, blaCTX-M1-like group was the most prevalent β-lactamase (n = 109), followed by blaTEM (n = 68), blaCTX-M2 (n = 22), and blaSHV (n = 2). By contrast to low resistance rate to IPM and ETP, we determined blaNDM in 31 isolates (22.1%). In co-prevalence of blaNDM-1 and ESBL-coding genes, a low carbapenem resistance was determined. We can confirm that blaCTX-M1-types are still the most frequent β-lactamase coding gene in Turkey. Our study showed the highest prevalence of blaNDM-1 metallo-β-lactamase coding gene in ESBL-producing E. coli.

  • 1.

    Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., Marchese, A.: The ARESC study: An international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34, 407413 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., Fishman, N. O.: Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32, 11621171 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., Coque, T. M.: Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14, 144153 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., Pascual, A.: Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42, 10891094 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Hanson, N. D., Moland, E. S., Hossain, A., Neville, S. A., Gosbell, I. B., Thomson, K. S.: Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. J Antimicrob Chemother 49, 10111014 (2002).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Bonnet, R.: Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 48, 114 (2004).

  • 7.

    Eckert, C., Gautier, V., Saladin-Allard, M., Hidri, N., Verdet, C., Ould-Hocine, Z., Barnaud, G., Delisle, F., Rossier, A., Lambert, T., Philippon, A., Arlet, G.: Dissemination of CTX-M-Type β-Lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48, 12491255 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Antony, S. J.: The changing epidemiology of extended spectrum Beta-lactamases (ESBL) infections of the urinary tract focusing on clinical resistance and therapeutic options. In Nikibakhsh, A. A. (ed): Clinical Management of Complicated Urinary Tract Infection. InTech, Rijeka, Croatia, 2011, pp. 1922.

    • Search Google Scholar
    • Export Citation
  • 9.

    Aykan, Ş. B., Çiftçi, I. H.: Antibiotic resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: A meta-analysis. Mikrobiyol Bul 47, 603618 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Melegh, S., Schneider, G., Horváth, M., Jakab, F., Emődy, L., Tigyi, Z.: Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital. Acta Microbiol Immunol Hung 62, 233245 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Poirel, L., Naas, T., Nordmann, P.: Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 54, 2438 (2010).

  • 12.

    Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. 24th Informational Supplement (M100-S24). CLSI, Wayne, PA (2014).

    • Search Google Scholar
    • Export Citation
  • 13.

    Cicek, C. A., Saral, A., Ozad, A. O., Yasar, E., Cizmeci, Z., Balci, P. O., Sari, F., Firat, M., Altintop, Y. A., Ak, S., Caliskan, A., Yildiz, N., Sancaktar, M., Budak, E. E., Erturk, A., Ozgumus, O. B., Sandalli, C.: Nationwide study of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV, and CTX-M in Turkey. J Antibiot 66, 647650 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Xu, L., Ensor, V., Gossain, S., Nye, K., Hawkey, P.: Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. J Med Microbiol 54, 11831187 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Moubareck, C., Brémont, S., Conroy, M. C., Courvalin, P., Lambert, T.: GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 58, 35793581 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Schechner, V., Straus-Robinson, K., Schwartz, D., Pfeffer, I., Tarabeia, J., Moskovich, R., Chmelnitsky, I., Schwaber, M. J., Carmeli, Y., Navon-Venezia, S.: Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 47, 32613265 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Jeon, B. C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., Young, D., Lee, J. H., Song, J. S., Lee, S. H.: Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 43, 22412245 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Iraz, M., Düzgün, A. Ö., Sandallı, C., Doymaz, M. Z., Akkoyunlu, Y., Saral, A., Peleg, A. Y., Özgümüş, O. B., Beriş, F. Ş., Karaoğlu, H., Çiçek, A. Ç.: Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey. Ann Lab Med 35, 595601 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G., Livermore, D. M.: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351353 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Cicek, A. Ç., Saral, A., Iraz, M., Ceylan, A., Duzgun, A. O., Peleg, A. Y., Sandallı, C.: OXA- and GESF-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect 20, 410415 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    El bouamri, M. C., Arsalane, L., Zerouali, K., Katfy, K., El kamouni, Y., Zouhair, S.: Molecular characterization of extended spectrum β-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. Afr J Urol 21, 161166 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Görgeç, S., Kuzucu, Ç., Otlu, B., Yetkin, F., Ersoy, Y.: Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates. Mikrobiyol Bul 49, 1525 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Kiremitci, A., Dinleyici, E. C., Erben, N., Durmaz, G., Yargic, Z. A., Aybey, A. D., Usluer, G.: In vitro activity of ertapenem and other carbapenems against extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey. Expert Opin Pharmacother 9, 14411449 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Kuzucu, Ç., Yetkin, F., Görgeç, S., Ersoy, Y.: Investigation of the susceptibilities of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems. Mikrobiyol Bul 45, 2835 (2011).

    • Search Google Scholar
    • Export Citation
  • 25.

    Hayakawa, K., Gattu, S., Marchaim, D., Bhargava, A., Palla, M., Alshabani, K., Gudur, U. M., Pulluru, H., Bathina, P., Sundaragiri, P. R., Sarkar, M., Kakarlapudi, H., Ramasamy, B., Nanjireddy, P., Mohin, S., Dasagi, M., Datla, S., Kuchipudi, V., Reddy, S., Shahani, S., Upputuri, V., Marrey, S., Gannamani, V., Madhanagopal, N., Annangi, S., Sudha, B., Muppavarapu, K. S., Moshos, J. A., Lephart, P. R., Pogue, J. M., Bush, K., Kaye, K. S.: Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. Antimicrob Agents Chemother 57, 40104018 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Lewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., Jorgensen, J. H.: First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 51, 40154021 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Kiratisin, P., Apisarnthanarak, A., Laesripa, C., Saifon, P.: Molecular characterization and epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing healthcare-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52, 28182824 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Shahcheraghi, F., Nikbin, V. S., Feizabadi, M. M.: Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist 15, 3739 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Ben-Ami, R., Rodríguez-Baño, J., Arslan, H., Pitout, J. D., Quentin, C., Calbo, E. S., Azap, O. K., Arpin, C., Pascual, A., Livermore, D. M., Garau, J., Carmeli, Y.: A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49, 682690 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Lin, C. F., Hsu, S. K., Chen, C. H., Huang, J. R., Lo, H. H.: Genotypic detection and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol 59, 665671 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Nordmann, P., Gniadkowski, M., Giske, C. G., Poirel, L., Woodford, N., Miriagou, V., The European Network on Carbapenemases: Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18, 432438 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Füzi, M.: Has the use of fluoroquinolone facilitated the widespread dissemination of methicllin-resistant Staphylococcus aureus and extended spectrum β-lactamase-producing Klebsiella pneumoniae in the healthcare setting? Acta Microbiol Immunol Hung 61, 399405 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 30 0 0
Mar 2021 11 0 0
Apr 2021 9 0 0
May 2021 19 0 0
Jun 2021 7 0 0
Jul 2021 9 0 0
Aug 2021 4 0 0